| Trial ID: | L6282 |
| Source ID: | NCT00364988
|
| Associated Drug: |
Pioglitazone+Losartan
|
| Title: |
Pioglitazone and Losartan Provides Additional Renoprotection
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Diabetic Nephropathy
|
| Interventions: |
DRUG: pioglitazone+losartan|DRUG: losartan
|
| Outcome Measures: |
Primary: Renal function, fasting glucose, HbA 1c , Scr, 24-hour urinary protein excretion, and endogenous creatinine clearance (Ccr), 12 month |
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01
|
| Completion Date: |
2006-01
|
| Results First Posted: |
|
| Last Update Posted: |
2014-10-27
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00364988
|
